Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Nancy, Bach"'
Autor:
Nathaniel S. Ash, Thomas D. Schiano, Joshua D. Safer, Maria I. Fiel, Aren H. Skolnick, Nancy Bach
Publikováno v:
Livers, Vol 4, Iss 3, Pp 314-319 (2024)
Background: As transgender people initiate gender-affirming hormone therapy (GAHT), they are exposed to exogenous sex hormones that have effects that have not yet been fully studied. While exogenous estrogen is associated with a risk of venous thromb
Externí odkaz:
https://doaj.org/article/3cce306f71ab4dafa57558137facd1ef
Autor:
Nancy Bach, Meena B. Bansal, Joseph A. Odin, Scott L. Friedman, David Del Bello, Jennifer Leong, Kian Bichoupan, Joshua Hartman, Douglas T. Dieterich, Michel Ng, Charissa Chang, Neeta Tandon, Sweta Chekuri, Lawrence U. Liu, Neal Patel, Thomas D. Schiano, Priya Grewal, Keith Sigel, Gene Y. Im, James F. Crismale, Ponni V. Perumalswami, Andrea D. Branch, Alyson Harty
Publikováno v:
World Journal of Virology
AIM To assess the real-world effectiveness and cost of simeprevir (SMV), and/or sofosbuvir (SOF)-based therapy for chronic hepatitis C virus (HCV) infection. METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin (RBV), SOF/
Autor:
Douglas T. Dieterich, Rachana Yalamanchili, Michel Ng, Ritu Agarwal, Neal Patel, Donald Gardenier, Meena B. Bansal, Jawad Ahmad, Viktoriya Khaitova, Thomas D. Schiano, Priya Grewal, Lawrence Ku, Scott L. Friedman, Kian Bichoupan, Charissa Chang, Andrea D. Branch, Joseph A. Odin, Jennifer Leong, Gene Im, David Motamed, Leona Kim-Schluger, Ponni V. Perumalswami, Nancy Bach, Lawrence Liu, Alyson Harty
To determine the safety profile of new hepatitis C virus (HCV) treatments in liver transplant (LT) recipients with recurrent HCV infection.Forty-two patients were identified with recurrent HCV infection that underwent LT at least 12 mo prior to initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf0144802b32cae72b0e10137c38915
https://europepmc.org/articles/PMC4778007/
https://europepmc.org/articles/PMC4778007/
Publikováno v:
Disease markers
Disease Markers, Vol 29, Iss 6, Pp 323-328 (2010)
Disease Markers, Vol 29, Iss 6, Pp 323-328 (2010)
Primary biliary cirrhosis (PBC) is an autoimmune disease of unclear etiology. It is a chronic, progressive condition that causes intrahepatic ductal destruction ultimately leading to symptoms of cholestasis, cirrhosis and liver failure. The disease p
Autor:
Hussein Elsiesy, Brent Peterson, Nancy Bach, Charissa Chang, Lawrence Liu, Thomas D. Schiano, Priya Grewal, Viktoriya Khaitova, Hatef Massoumi, Edward Norkus
Publikováno v:
Transplantation. 88:729-735
BACKGROUND To lessen the severity of recurrent hepatitis C virus (HCV) postliver transplantation (post-LT) by treating HCV patients with cirrhosis, we assessed the safety and efficacy of an escalating dose pegylated interferon (PEG-IFN)/ribavirin pro
Autor:
Nancy Bach, Jorge Allina, Joseph A. Odin, Carol A. Bodian, Henry C. Bodenheimer, Carmen M. Stanca
Publikováno v:
Digestive Diseases and Sciences. 53:1988-1993
Statin treatment reduces hypercholesterolemia and may be anti-inflammatory. Case reports noted decreased alkaline phosphatase and histological improvement following statin treatment in primary biliary cirrhosis. The objective of this study was to ass
Autor:
Jose Lopez, Carmen M. Stanca, Henry C. Bodenheimer, Julio A. Gutierrez, Nidhi Tandon, Andrea D. Branch, Carol A. Bodian, Cynthia Krause, Nancy Bach, Joseph A. Odin, Maria A. Freni, Paul D. Berk
Publikováno v:
The American Journal of Gastroenterology. 100:1104-1109
OBJECTIVES: Fatigue, which may have a significant impact on quality of life, is the most common reported symptom in primary biliary cirrhosis (PBC). Multiple instruments to quantify fatigue and quality of life in liver disease have been validated, bu
Autor:
Hulya Levendoglu, Franklin M. Klion, Furqaan Ahmed, Nancy Bach, Jane M Geders, Ira M. Jacobson, Robert S. Brown, Edward Lebovics, Hillel Tobias, Stephen Esposito, Louis V. Antignano, Douglas T. Dieterich, David Gabbaizadeh, Mark W. Russo
Publikováno v:
The American Journal of Gastroenterology. 99:1700-1705
OBJECTIVES: Most studies establishing the role of antiviral therapy in patients with chronic hepatitis C (CHC) excluded the patients with normal ALT levels. Small trials with interferon monotherapy suggested a limited efficacy and/or de novo ALT elev
Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment
Autor:
Bruce Zweiban, Stuart C. Gordon, Nancy Bach, Marlyn J. Mayo, Robert G. Gish, Pietro Invernizzi, Mauro Podda, Hiromi Ishibashi, Harlan I. Wright, Carlo Selmi, M. Eric Gershwin
Publikováno v:
Gastroenterology. 127:485-492
Background & Aims: There is growing evidence that the interplay of genetic susceptibility and environmental factors leads to primary biliary cirrhosis (PBC). In particular, family members of an infected individual have up to a 100-fold higher risk of
Autor:
Paul D Berk, Thierry Therneau, Keith D. Lindor, Edward Croen, Nancy Bach, Henry C. Bodenheimer, Swan N. Thung, Carol A. Bodian, Fenton Schaffner
Publikováno v:
The American Journal of Gastroenterology. 98:187-193
Objective Preliminary data suggested possible benefits of methotrexate in primary biliary cirrhosis. We assessed the effectiveness of methotrexate use in primary biliary cirrhosis and its tolerance in patients with this disease. Methods A total of 11